June 24 (Reuters) - Curasight A/S CURAS.TE :
* POSITIVE DATA OF UTREAT® IN GLIOBLASTOMA PROVIDES "GREEN
LIGHT"
TO PROCEED WITH NEXT STEPS
* BIODISTRIBUTION RESULTS FROM CURASIGHT A/S' ("CURASIGHT")
TESTING OF UTREAT® FOR TREATMENT OF GLIOBLASTOMA ARE NOW
AVAILABLE
* RESULTS ARE POSITIVE AND PROVIDE "GREEN LIGHT" TO PROCEED
TO
NEXT STEP
* FIRST STEP IN TESTING NEW TARGETED RADIONUCLIDES IS STUDY
OF
BIODISTRIBUTION
Source text for Eikon: ID:nWkr75RylP
Further company coverage: CURAS.TE
((reuters.briefs@thomsonreuters.com;))